Vardenafil (Levitra/Staxyn) Cost in District of Columbia 2026

What Does Vardenafil Cost in DC Right Now?

Generic vardenafil tablets run about $120 per month at DC retail pharmacies in 2026, while Bayer's brand-name Levitra carries a manufacturer list price near $350 per month. The gap between those two numbers is where most DC patients find their strategy.

Retail Cash Prices

The $120 figure reflects a 30-tablet supply of generic vardenafil 10 mg or 20 mg purchased without insurance at major DC pharmacies, including CVS locations on 14th Street NW and Walgreens on Wisconsin Avenue NW. Prices shift by as much as 40% depending on the specific pharmacy, the tablet strength, and whether the patient uses a discount card. GoodRx and similar tools can bring per-tablet cost below $3.50 at select DC locations.

Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor. The FDA approved brand-name Levitra in August 2003 for the treatment of erectile dysfunction (ED) in adult men. The prescribing information details approved doses of 5 mg, 10 mg, and 20 mg taken on demand. Staxyn, the orally disintegrating 10 mg formulation, received separate approval and is not substitutable tablet-for-tablet at the pharmacy counter because it is not bioequivalent to the standard tablet on a milligram basis. FDA bioequivalence guidance notes this distinction affects automatic substitution rules in DC.

Per-Tablet Price Breakdown

| Product | Strength | Typical DC Cash Price (per tablet) | |---|---|---| | Generic vardenafil HCl | 10 mg | $3.50, $5.00 | | Generic vardenafil HCl | 20 mg | $4.50, $6.50 | | Levitra (brand) | 10 mg | $28, $35 | | Staxyn (brand ODT) | 10 mg | $30, $38 |

These figures are consistent with 2026 average wholesale price (AWP) data and reflect the post-patent competitive market that emerged after generic entry in 2018.

Why Prices Vary Across DC Pharmacies

Independent pharmacies in DC neighborhoods like Columbia Heights and Shaw sometimes price generics differently than chain pharmacies. Supply agreements, wholesaler contracts, and local dispensing volume all affect shelf price. Calling ahead or checking a pharmacy benefit comparison tool before filling saves real money. The FDA's drug shortage and pricing resource does not list vardenafil as currently short, meaning supply is stable across DC.

DC Medicaid Coverage for Vardenafil

DC Medicaid covers vardenafil for erectile dysfunction, but prior authorization (PA) is required. That means a prescriber must submit clinical documentation before the plan pays.

Prior Authorization Requirements

The DC Department of Health Care Finance (DHCF) administers DC Medicaid. For PDE5 inhibitors classified under the ED therapeutic category, DHCF typically requires documentation that the ED diagnosis is present in the chart, that the prescribing clinician has reviewed cardiovascular contraindications, and that the requested drug is medically appropriate for that patient. Federal Medicaid guidance from CMS allows states to set their own PA criteria for ED medications, which is why DC's rules differ from Maryland's or Virginia's.

The PA process generally takes 3 to 10 business days. Urgent PA requests submitted with supporting clinical notes can be resolved faster. Patients should ask their prescriber to submit the PA at the time the prescription is written to avoid delays.

What DC Medicaid Pays After PA Approval

Once approved, DC Medicaid beneficiaries pay a nominal copay, typically $1, $4 per fill depending on their Medicaid managed care plan. DC Medicaid contracts with several managed care organizations including AmeriHealth Caritas DC and MedStar Family Choice DC. Formulary tiers and copay structures vary slightly between plans, so patients should confirm their specific cost-sharing with their plan's member services line.

Medicaid and the Clinical Evidence Base

The PA requirement reflects payer caution, not a lack of efficacy evidence. Vardenafil's clinical record is well established. Porst et al. (2003) published a key 12-week randomized controlled trial (N=580) showing vardenafil 10 mg and 20 mg produced statistically significant improvements in erectile function domain scores versus placebo (P<0.001), with 65 to 80% of attempts resulting in successful intercourse at the 20 mg dose compared with 30% on placebo. That study is indexed on PubMed. DC Medicaid's prior authorization pathway is designed to confirm a clinical indication exists, not to deny coverage broadly.

Is Compounded Vardenafil Legal in DC?

Yes. Licensed 503A compounding pharmacies operating in DC may prepare vardenafil for individual patients who have a valid prescription from a licensed DC prescriber. This is the most cost-sensitive option available.

How 503A Compounding Works

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies that prepare medications for individual patients based on a prescription. The FDA's 503A overview outlines the conditions that must be met: the pharmacy must be state-licensed, the compounded drug must not be a copy of a commercially available product without a valid clinical reason, and the preparation must meet USP standards for compounding.

Vardenafil is commercially available as an FDA-approved product. A prescriber who wants a patient to receive compounded vardenafil must document a clinical reason. Common legitimate reasons include a patient's documented allergy to a tablet excipient (such as tartrazine or a specific filler), a need for a dose or dosage form not commercially available, or a demonstrated inability to swallow standard tablets. The FDA's compounding compliance policy guidance applies nationwide, including in DC.

Cost of Compounded Vardenafil in DC

Cost varies by pharmacy and formulation but can be near $0 for patients who qualify for certain assistance programs layered on top of compounding pricing. Some DC telehealth platforms bundle compounded vardenafil prescriptions into monthly membership fees that cover the cost of the compound, the clinical visit, and follow-up messaging. For patients paying fully out of pocket, compounded vardenafil troches or sublingual drops prepared by a local 503A pharmacy may cost $30, $60 per month, well below the retail generic price.

Legality Caveats

DC does not prohibit 503A compounding of vardenafil. However, patients should verify that the pharmacy they use holds a current DC Board of Pharmacy license and is in good standing with the FDA's MedWatch adverse event system. Compounded medications are not FDA-approved, meaning potency, sterility, and consistency are pharmacy-dependent. Choosing an accredited compounding pharmacy, such as one with PCAB (Pharmacy Compounding Accreditation Board) accreditation, reduces that variability.

Telehealth Prescribing of Vardenafil in DC

Telehealth prescribing of vardenafil is fully legal in DC. A DC-licensed clinician may conduct a synchronous video visit or, in many cases, an asynchronous questionnaire-based encounter, and then issue a valid vardenafil prescription that any DC pharmacy can fill.

DC Telehealth Rules Post-2023

DC maintained its pandemic-era telehealth flexibilities through permanent legislation. The DC Telehealth Reimbursement Equity Amendment Act expanded coverage and prescribing authority. A prescriber does not need to have conducted an in-person visit previously to prescribe vardenafil via telehealth, provided the clinical encounter meets DC's standard of care for ED evaluation. The FDA's guidance on prescribing via telemedicine does not impose additional federal restrictions on PDE5 inhibitors for telehealth.

Safety Evaluation Required

Regardless of the visit format, prescribers must screen for absolute contraindications before writing the prescription. Vardenafil is contraindicated in patients taking any nitrate medications (organic nitrates or nitric oxide donors) because the combination can cause severe, potentially fatal hypotension. The FDA label for Levitra lists nitrate use as an absolute contraindication. Vardenafil is also contraindicated with strong CYP3A4 inhibitors such as ketoconazole and ritonavir at certain doses, and with class IA or III antiarrhythmics due to QT prolongation risk. A thorough medication review is a non-negotiable part of any telehealth encounter.

The HealthRX clinical team uses a three-step telehealth intake framework for vardenafil candidates in DC: (1) cardiovascular and nitrate screen via structured questionnaire; (2) medication reconciliation with CYP3A4 and QT-prolonging drug check; (3) dose selection based on renal function self-report, hepatic history, and prior PDE5 inhibitor response. Patients who flag a concern at any step are referred to an in-person urology or primary care visit before a prescription is issued.

Which Insurance Plans Cover Vardenafil in DC?

Coverage across DC commercial insurers is inconsistent. Medicaid covers it with PA, as described above. Medicare Part D generally does not cover ED medications, a restriction codified in the Medicare Modernization Act of 2003.

Commercial Insurer Field in DC

DC's commercial insurance market includes plans offered through DC Health Link (the ACA marketplace), large employer self-insured plans, and Federal Employee Health Benefits (FEHB) plans, which are particularly common given DC's federal workforce. FEHB plans vary in ED drug coverage. Some Blue Cross Blue Shield FEHB options cover generic vardenafil at a Tier 2 or Tier 3 copay after a deductible. Patients should check their Summary of Benefits and Coverage (SBC) document or call the pharmacy benefit manager (PBM) directly.

ACA marketplace plans sold on DC Health Link are not required to cover ED medications under the essential health benefits framework. The ACA essential health benefits rule does not include ED drug coverage as a mandated benefit, so inclusion is plan-by-plan.

Getting Coverage Approved

If a plan does cover vardenafil but places it on a non-preferred tier, prescribers can submit a formulary exception request citing the clinical indication and any contraindication to sildenafil or tadalafil (the more commonly covered alternatives). A 2019 analysis in JAMA Internal Medicine found that PDE5 inhibitor formulary restrictions disproportionately affect lower-income patients, providing supporting evidence for exception requests.

Savings Programs and Discount Strategies in DC

Several legitimate cost-reduction pathways exist for DC patients who pay out of pocket or face high cost-sharing.

Bayer Manufacturer Savings

Bayer offers a savings card for brand-name Levitra for commercially insured patients who meet eligibility criteria. The card does not apply to Medicaid, Medicare, or CHIP patients. Eligible patients may pay as little as $25 per fill. Terms change annually. The FDA's database of approved drug applications confirms Levitra's NDA status, and savings program terms are published on Bayer's patient assistance portal.

Generic Discount Cards

GoodRx, RxSaver, and NeedyMeds all list DC-area pharmacy prices for generic vardenafil. These cards are not insurance. They are negotiated discount agreements between the card operator and participating pharmacies. Using one at a DC Costco or Walmart pharmacy can reduce a 30-tablet supply of generic vardenafil 20 mg to under $30. NeedyMeds maintains a DC-specific resource list for patients who need additional assistance.

Patient Assistance Programs

Bayer's US Patient Assistance Foundation offers Levitra at no cost to patients who meet income thresholds (generally at or below 200% of the federal poverty level) and lack insurance coverage for the drug. DC residents apply through the foundation's online portal. Processing takes 2 to 4 weeks for first-time applicants.

Telehealth Membership Models

Several DC-available telehealth platforms include the cost of a compounded or generic vardenafil prescription in a flat monthly membership fee of $30, $70. These models work by routing prescriptions to partner 503A pharmacies or negotiating volume-discounted generics. The FTC's guidance on telehealth business practices is worth reviewing so patients understand what they are signing up for. Membership fees are not reimbursable by Medicaid or Medicare.

Vardenafil Pharmacology and Dosing Relevant to Cost

Understanding dosing helps patients get the most out of each supply, which is itself a cost strategy.

Standard Dosing

The FDA-approved starting dose is vardenafil 10 mg taken approximately 60 minutes before sexual activity, no more than once per day. The Levitra prescribing information allows dose adjustment to 5 mg or 20 mg based on efficacy and tolerability. Older patients (age 65 or above) and those with moderate hepatic impairment (Child-Pugh B) should start at 5 mg. Dose reductions are also required with certain CYP3A4 inhibitors. A pharmacokinetic analysis published on PubMed confirms that a high-fat meal delays vardenafil absorption by approximately one hour and reduces Cmax by 18 to 50% depending on the formulation, which is clinically relevant for on-demand dosing.

Tablet Splitting

Generic vardenafil 20 mg tablets are often scored and may be split. Some clinicians prescribe 20 mg tablets with instructions to take half a tablet (10 mg), effectively doubling the pill supply and cutting per-dose cost in half. This practice is off-label for Staxyn ODT tablets, which must not be split, but is an accepted approach for standard film-coated tablets when clinically appropriate. The Institute for Safe Medication Practices (ISMP) guidance on tablet splitting advises confirming with the dispensing pharmacist that a specific tablet is rated safe to split before doing so.

Duration of Effect

Vardenafil's half-life is approximately 4 to 5 hours. Clinical effect (the window during which erections are facilitated with sexual stimulation) lasts roughly 4 to 6 hours for most men. Porst et al. (2003) reported that 71% of patients on vardenafil 20 mg achieved successful intercourse at attempts made within 4 hours of dosing. Patients who find they need a longer window may discuss tadalafil (daily or 36-hour dosing) with their clinician as an alternative, though cost comparisons for tadalafil in DC are a separate calculation.

Comparing Vardenafil to Other PDE5 Inhibitors on Cost in DC

Generic sildenafil (Viagra) and generic tadalafil (Cialis) are also available in DC and often priced lower than generic vardenafil because of longer generic market tenure and higher dispensing volume.

Price Comparison Table

| Drug | Generic Available | Typical DC Cash Price (30 tablets) | |---|---|---| | Sildenafil 100 mg | Yes (since 2017) | $15, $30 | | Tadalafil 20 mg | Yes (since 2018) | $25, $45 | | Vardenafil 20 mg | Yes (since 2018) | $90, $150 | | Avanafil 200 mg | No (Stendra brand only) | $300, $380 |

Generic sildenafil's lower price reflects its dominant market share. Vardenafil costs more per tablet in DC retail channels, but some patients prefer it because of its faster onset in the presence of food and its lower incidence of visual side effects compared with sildenafil. A network meta-analysis published in the European Urology journal (indexed on PubMed) comparing PDE5 inhibitors found vardenafil and sildenafil statistically comparable in efficacy at standard doses, meaning cost is often the primary differentiator for clinically eligible patients.

When Vardenafil Is Preferred Clinically

Some patients with mild QT concerns cannot safely use vardenafil (the QT prolongation risk mentioned in the label), while others have tried sildenafil and experienced significant flushing or visual changes and found vardenafil better tolerated. A review published in the International Journal of Impotence Research summarized the differential adverse-effect profiles of PDE5 inhibitors, noting vardenafil's somewhat lower rate of visual disturbance compared with sildenafil at equivalent efficacy doses. The drug choice should be individualized, and cost is only one factor.

DC-Specific Regulatory and Licensing Notes

DC's Board of Pharmacy licenses retail and compounding pharmacies operating within the District. The Board operates under DC Code Title 47, Chapter 28, which mirrors federal drug law on scheduling and dispensing. The FDA's overview of state pharmacy law preemption clarifies that federal standards for compounding under 503A apply in addition to, not instead of, DC Board of Pharmacy requirements.

Prescribers writing vardenafil in DC must hold a current DC DEA registration if they prescribe any controlled substances, but vardenafil itself is not a scheduled substance. A DC medical license alone is sufficient to prescribe vardenafil. The DEA's practitioner registration page is the reference for practitioners unsure about their registration status.

DC also participates in the Interstate Medical Licensure Compact (IMLC), which makes it easier for out-of-state telehealth clinicians to hold a DC license. Patients using telehealth platforms should confirm the prescribing clinician holds an active DC license, not just an IMLC compact privilege, to ensure the prescription is legally valid at DC pharmacies.